NASDAQ · Financial Statements
BioCardia, Inc. (BCDA) Financial Statements
$1.04
NASDAQ: BCDA
Market Cap $15.48M
Overview Financials Dividend BioCardia, Inc. most recently reported annual revenue of $0, net profit of $-8.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $1.0M $1.0M $0 $0 $0 Operating Profit $-13.0M $-12.0M $-12.0M $-8.0M $-8.0M Net Profit $-13.0M $-12.0M $-12.0M $-8.0M $-8.0M EPS $-11.19 $-10.05 $-8.19 $-2.90 $-1.23 Op Margin -1244.3% -880.3% -2441.1% -13794.8% —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $16.0M $10.0M $3.0M $4.0M $3.0M Total Liabilities $5.0M $5.0M $5.0M $3.0M $3.0M Cash $13.0M $7.0M $1.0M $2.0M $2.0M Borrowings $2.0M $2.0M $1.0M $1.0M $1.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-10.0M $-11.0M $-10.0M $-8.0M $-7.0M Investing Cash Flow $0 $0 $0 $0 $0 Financing Cash Flow $0 $0 $-1.0M $-1.0M $0 Net Cash Flow $-9.0M $-6.0M $-6.0M $1.0M $0 Free Cash Flow $-10.0M $-11.0M $-10.0M $-8.0M $-7.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.01 EV / EBITDA -2.00 FCF Yield -43.48% Quick Ratio 2.09 Interest Coverage 0.00 Return 1Y -61.57% Return 3Y -97.49% Return 5Y -98.27%
Screens featuring this stock